Serum prolactin levels in HLA-B27-associated uveitis

European Journal of Ophthalmology

Volumn 18, Issue 6, 2008, Pages 929-933

  Proença, Helena Sofia Ferrão Mesquita ^a,b   Ferreira, C ^a   Miranda, M ^a   Castanheira Dinis, A ^a   Monteiro Grillo, M ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Antinuclear antibodies; Arthritic disorders; Cytokines; HLA B27 associated uveitis; Prolactin

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; HLA B27 ANTIGEN; METHOTREXATE; PROLACTIN; SALAZOSULFAPYRIDINE;

ADOLESCENT; ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTHRITIS; ARTICLE; AUTOIMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERPROLACTINEMIA; MALE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RHEUMATIC DISEASE; SCHOOL CHILD; UVEITIS; BLOOD; CHEMOLUMINESCENCE; CLINICAL TRIAL; COMPARATIVE STUDY; IMMUNOLOGY; IRIDOCYCLITIS; MIDDLE AGED; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHEMILUMINESCENT MEASUREMENTS; CHILD; FEMALE; HLA-B27 ANTIGEN; HUMANS; MALE; MIDDLE AGED; PROLACTIN; PROSPECTIVE STUDIES; SPONDYLITIS, ANKYLOSING; UVEITIS, ANTERIOR;

EID: 58149386660     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210801800612     Document Type: Article

References (18)

1. Jara LJ, Silveira LH, Cuellar M, Pineda C, Scopelitis E, Espinosa L. Hyperprolactinemia in Reiter's syndrome. J Rheumatol 1994; 21: 1292-7.
2. Kawai T, Katoh K, Tani K. Hyperprolactinemia preceding development of autoimmune disease. J Rheumatol 1996; 23: 1483-4.
3. Reber PM. Prolactin and immunomodulation. Am J Med 1993; 95: 637-44.
4. Toubi E, Gabriel D, Golan TD. High association between hyperprolactinemia and anticardiolipin antibodies. J Rheumatol 1997; 24: 1451.
5. Walker SE, Jacobson JD. Roles of prolactin and gonadotropin-releasing hormone in rheumatic diseases. Rheum Dis Clin North Am 2000; 26: 713-36.
6. Houman H, Ben GI, Lamloum M, et al. Prolactin levels in Beh&et's disease: no correlation with disease manifestations and activity. Ann Med Intern 2001; 152: 209-11.
7. Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA B-27. Surv Ophthalmol 2005; 50: 364-88.
8. Jamil A, Thompson L, Singh S, Ahuja R, Dray P, Becker N. Incidence and causes of uveitis in a suburban general ophthalmology clinic. Invest Ophthalmol Vis Sci 2003; 44: 772-4.
9. Suhler EB, Martin TM, Rosenbaum JT. HLA-B27-associated uveitis: overview and current perspectives. Curr Opin Ophthalmol 2003; 14: 378-83.
10. Power WJ, Rodriguez A, Pedroza-Seres M, Foster CS. Outcomes in anterior uveitis associated with the HLA-B27 haplotype. Ophthalmology 1998; 105: 1646-51.
11. Rosenbaum JT, Smith JR. Anti-TNF therapy for eye involvement in spondyloarthropathy. Clin Exp Rheumatol 2002; 20: S143-5.
12. Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A. Ankylosing spondylitis: an overview. Ann Rheum Dis 2002; 61: iii8-iii18.
13. Braun J, Bollow M, Remlinger G, et al. Prevalence of spondyloarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998; 41: 58-67.
14. Monnet D, Breban M, Hudry C, Dougados M, Brezin AP. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology 2004; 111: 802-9.
15. Pato E, Banares A, Jover JA, et al. Undiagnosed spondyloarthropathy in patients presenting with anterior uveitis. J Rheumatol 2000; 27: 2198-202.
16. Eastmond CJ. Genetics and HLA antigens. Baillieres Clin Rheumatol 1994; 8: 263-76.
17. Reveille J, Conant M, Duvic M. Human immunodeficiency virus-associated psoriasis, psoriatic arthritis, and Reiter's syndrome: a disease continuum? Arthritis Rheum 1990; 33: 1574-8.
18. Kavanaugh A, Tomar R, Reveille J, et al. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med 2000; 124: 71.